|
|
|
|
|
|
|
|
|
|
|
28.11.25 - 21:12
|
Cereno Scientific: Major shareholders and new investors back the Company′s long-term strategy with equity investment at a premium (Cision)
|
|
|
Cereno Scientific (Nasdaq First North: CRNO B) (the “Company”), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, announced that major long-term shareholders and new investors have confirmed their strong support by participating in the recently communicated financing arrangement, amounting to a total of up to SEK 650 million with SEK 100 million raised in a directed share issue (the “Directed Issue”), warrants with premium strike prices that may add further equity capital of up to 200 million, and up to SEK 350...
|
|
|
28.11.25 - 21:12
|
Cereno Scientific Secures SEK 100m in Directed Share Issue and Loan Financing of SEK 350m Reaching Milestones in Q4-2027 (Cision)
|
|
|
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEELAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.
Cereno Scientific (Nasdaq First North: CRNO B) (the “Company”), an innovative biotech pioneering treatments to enhance and extend...
|
|
|
|
|
|
|
|
|
28.11.25 - 18:36
|
Number of shares and votes in BioArctic AB (publ) as of November 28, 2025 (Cision)
|
|
|
Stockholm, November 28, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 4,000 Class B shares during November for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 4,000 stock options of series 2019/2028.
As of November 28, 2025, the last trading day of the month, the total number of shares in BioArctic AB amounted to 88,641,485 shares, of which 74,241,489 listed Class B shares and 14,399,996 unlisted Class A shares. The A...
|
|
|
|
|
|
|
28.11.25 - 17:42
|
TAGESVORSCHAU: Termine am 1. Dezember 2025 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Montag, den 1. Dezember 2025^TERMINE UNTERNEHMEN16:00 CHE: Novartis, Social Impact & Sustainability Annual Investor EventTERMINE KONJUNKTUR00:50 JPN: Investitionen ......
|
|
|
|
|
|
|
|
|
|
|
28.11.25 - 17:06
|
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purchase Program (Cision)
|
|
|
Tromsø, Norway, November 28th, 2025 - Reference is made to the stock exchange announcement published by ArcticZymes Technologies ASA (the "Company", OSE: AZT) on 25 November 2025 announcing the initiation of a share buyback program pursuant to the authorization granted by the Annual General Meeting held on 27 May 2025.
The share buyback program has now been completed. From and including 25 November 2025 to and including 28 November 2025, the Company has purchased a total of 31,365 own shares at an average price of NOK 22.5037 per share. Please see the attached table for further details....
|
|
|
|
|
28.11.25 - 15:42
|
Xlife-Portfoliounternehmen hat angepasstes Formular für Nasdaq-IPO eingereicht (Cash)
|
|
|
- Die Xlife-Portfoliogesellschaft Veraxa Biotech muss bei ihrem geplanten Börsengang an Nasdaq eine Ehrenrunde drehen. Veraxa, die Gesellschaft soll über einen Merger mit der bereits Nasdaq-kotierten Firma Voyager Acquisition an die Börse kommen, hat Ende November eine überarbeitete Fassung der Registrierungserklärung (Form F-4) eingereicht....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
